- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 45 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 416 publications
- Percutaneous Coronary Intervention , 211 publications
- Clopidogrel , 189 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All
My publications
Filter publications
844 publications
2025
Switching from cangrelor to oral P2Y12 inhibitors: a focused review on drug-drug interactions.
Expert opinion on drug metabolism & toxicology
鈥�2025
Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI.
The New England journal of medicine
鈥�2024
Management of Antiplatelet Therapy After Coronary Stenting in Patients Requiring Noncardiac Surgery.
Journal of the American College of Cardiology
鈥�2024
Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study).
Clinical cardiology
鈥�2024
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
JAMA cardiology
鈥�